Literature DB >> 26387473

The impact of high-sensitivity troponin implementation on hospital operations and patient outcomes in 3 tertiary care centers.

Kathryn R Crowder1, Tristan D Jones2, Eddy S Lang1, Dongmei M Wang1, Steven M Clark1, Grant D Innes1, James D McMeekin1, Michelle M Graham3, Andrew D McRae4.   

Abstract

OBJECTIVE: High-sensitivity troponin T (hs-TnT) assays detect myocardial injury sooner, possibly improving throughput times for emergency department (ED) assessment of suspected acute myocardial infarction (AMI). This study evaluates the influence of hs-TnT implementation on ED length of stay (LOS), consultations and admissions, as well as ED revisits with cardiology admissions for patients undergoing testing for suspected AMI.
METHODS: This control pre-post design analysis included patients evaluated using hs-TnT or conventional troponin T. Data were collected from 3 ED databases for patients who had a troponin assay for suspected AMI for the periods February 12, 2011-April 22, 2011 (Ctrl); November 20, 2011-January 28, 2012 (Pre); and February 12, 2012-April 21, 2012 (Post). The primary outcome was ED LOS; secondary outcomes included the proportions of patients who received ED cardiology consultations, patients who were admitted to hospital, and discharged patients who revisited the ED within 30 days.
RESULTS: Data were analyzed from 6650 (Ctrl), 6866 (Pre), and 5754 (Post) patients. Median ED LOS decreased following hs-TnT implementation (6.60 hours in Ctrl and Pre vs 6.10 hours in Post, P < .001). There was no change in cardiology consultations or admissions following hs-TnT implementation. Fewer ED revisits occurred within 30 days in Post (16.0% Ctrl, 16.5% Pre vs 14.9% Post; P < .01). These results were preserved after adjusting for age and Canadian Triage Acuity Score.
CONCLUSIONS: This hs-TnT implementation strategy, using an equivalent cutoff for the conventional troponin T and hs-TnT assays, decreased ED LOS for patients with suspected AMI and did not increase cardiology resource utilization or ED revisits.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26387473     DOI: 10.1016/j.ajem.2015.08.041

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Emergency Department Management of Chest Pain With a High-Sensitivity Troponin-Enabled 0/1-Hour Rule-Out Algorithm.

Authors:  Nicholas J Bevins; Hyojin Chae; Jacqueline A Hubbard; Edward M Castillo; Vaishal M Tolia; Lori B Daniels; Robert L Fitzgerald
Journal:  Am J Clin Pathol       Date:  2022-05-04       Impact factor: 5.400

2.  Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay.

Authors:  Bryn E Mumma; Scott D Casey; Robert K Dang; Michelle K Polen; Jasmanpreet C Kaur; John Rodrigo; Daniel J Tancredi; Robert A Narverud; Ezra A Amsterdam; Nam Tran
Journal:  Ann Emerg Med       Date:  2020-08-15       Impact factor: 5.721

3.  Undetectable Concentrations of a Food and Drug Administration-approved High-sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival.

Authors:  Andrew D McRae; Grant Innes; Michelle Graham; Eddy Lang; James E Andruchow; Yunqi Ji; Shabnam Vatanpour; Tasnima Abedin; Hong Yang; Danielle A Southern; Dongmei Wang; Isolde Seiden-Long; Lawrence DeKoning; Peter Kavsak
Journal:  Acad Emerg Med       Date:  2017-08-11       Impact factor: 3.451

4.  High Sensitivity Cardiac Troponin Assays - How to Implement them Successfully.

Authors:  Frederick K Korley; Allan S Jaffe
Journal:  EJIFCC       Date:  2016-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.